Kratos Opens New 10,000 Sq Ft Facility for Engine Overhaul Business in British Colombia GlobeNewswire December 05, 2025 SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, today announced the opening of its new stateâ€'ofâ€'theâ€'art 10,000 square foot facility […]

Lelantos Holdings Engages Aloba, Awomolo & Partners as PCAOB-Approved Auditor to Support Planned Uplift to OTCQB Firm retained to complete financial audits and strengthen reporting standards ahead of anticipated market tier upgrade GlobeNewswire December 05, 2025 TUCSON, Ariz., Dec. 05, 2025 (GLOBE NEWSWIRE) — via IBN – Lelantos Holdings, Inc. (OTCID: LNTO) (“Lelantos” or the

Stran & Company Launches Client-Branded Online Gifting Platform; First Deployment Begins with One of the World's Largest Audit, Tax, and Advisory Firms New Platform Expands Stran's Digital Capabilities and Introduces a New and Scalable Recurring Revenue Stream GlobeNewswire December 05, 2025 Quincy, MA, Dec. 05, 2025 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or

Vertex and CPA.com Announce AI-Driven Expansion of Tax Compliance Services for Accounting Firms GlobeNewswire December 05, 2025 KING OF PRUSSIA, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) — Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, and CPA.com, the trusted partner in accounting and finance transformation, today announced an

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models AI-Driven Risk Prediction for Breast, Prostate and Pancreatic Cancers GlobeNewswire December 05, 2025 TOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) — A.D.A.M. Innovations Co. (Japanese Name: Genesis Healthcare Co.) (“A.D.A.M. Innovations” or the “Company”), Japan's leading AI-driven genomics company, today announced the release of three new

Iterum Therapeutics Provides Business Update GlobeNewswire December 05, 2025 DUBLIN and CHICAGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today

Holzer & Holzer, LLC Reminds Investors of Upcoming December 8, 2025 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Marex, Inc. (MRX), aTyr Pharma, Inc. (ATYR), WPP plc (WPP) , and Cepton, Inc. (CPTN) GlobeNewswire December 05, 2025 ATLANTA, Dec. 05, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 05, 2025 PRINCETON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 14

LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 05, 2025 LOS ANGELES, Dec. 05, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) for

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT(R) for Parkinson's Disease GlobeNewswire December 05, 2025 Interim data show substantial improvements in “Good On” time compared to other oral CD/LD therapies CREXONT delivered substantial “Off” time reductions, improved motor symptom control and provided a longer duration of benefit with each dose Findings highlight CREXONT